At the crossroads: EGFR and PTHrP signaling in cancer-mediated diseases of bone

被引：11
作者：
Foley, John [1 ,2 ,3 ]
Nickerson, Nicole [1 ]
Riese, David J., II [4 ]
Hollenhorst, Peter C. [1 ,3 ]
Lorch, Gwendolen [5 ]
Foley, Anne M. [1 ]
机构：
[1] Indiana Univ, Sch Med, Bloomington, IN 47405 USA
[2] Indiana Univ, Sch Med, Dept Dermatol, Indianapolis, IN 46202 USA
[3] Indiana Univ, Sch Med, Simon Canc Ctr, Indianapolis, IN 46202 USA
[4] Auburn Univ, Harrison Sch Pharm, Auburn, AL 36830 USA
[5] Ohio State Univ, Coll Vet Med, Dept Vet Clin Sci, Columbus, OH 43210 USA
来源：
ODONTOLOGY | 2012年 / 100卷 / 02期
关键词：
PTHrP; EGFR; Gene expression; Squamous cell carcinoma; Bone metastasis; Hypercalcemia; EPIDERMAL-GROWTH-FACTOR; HORMONE-RELATED PROTEIN; NONSMALL CELL LUNG; RECEPTOR TYROSINE KINASES; CALCIUM-SENSING RECEPTOR; BREAST-CANCER; NEVER-SMOKERS; HEPARIN-BINDING; GENE-EXPRESSION; FACTOR-ALPHA;
D O I：
10.1007/s10266-012-0070-5
中图分类号：
R78 [口腔科学];
学科分类号：
1003 ;
摘要：
The epidermal growth factor receptor is a well-established cancer therapeutic target due to its stimulation of proliferation, motility, and resistance to apoptosis. Recently, additional roles for the receptor have been identified in growth of metastases. Similar to development, metastatic spread requires signaling interactions between epithelial-derived tumor cells and mesenchymal derivatives of the microenvironment. This necessitates reactivation of developmental signaling molecules, including the hypercalcemia factor parathyroid hormone-related protein. This review covers the variations of epidermal growth factor receptor signaling in cancers that produce bone metastases, regulation of parathyroid hormone-related protein, and evidence that the two molecules drive cancer-mediated diseases of bone.
引用
收藏
页码：109 / 129
页数：21
相关论文
共 203 条
  • [41] Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation
    Elenius, K
    Paul, S
    Allison, G
    Sun, J
    Klagsbrun, M
    [J]. EMBO JOURNAL, 1997, 16 (06) : 1268 - 1278
  • [42] ENCODE Project Consortium, 2011, PLoS Biol, V9
  • [43] FERRARI SL, 1994, J BONE MINER RES, V9, P639
  • [44] PARATHYROID HORMONE-RELATED PROTEIN-PRODUCTION BY PRIMARY CULTURES OF MAMMARY EPITHELIAL-CELLS
    FERRARI, SL
    RIZZOLI, R
    BONJOUR, JP
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 1992, 150 (02) : 304 - 311
  • [45] Cigarette Smoke Induces Aberrant EGF Receptor Activation That Mediates Lung Cancer Development and Resistance to Tyrosine Kinase Inhibitors
    Filosto, Simone
    Becker, Cathleen R.
    Goldkorn, Tzipora
    [J]. MOLECULAR CANCER THERAPEUTICS, 2012, 11 (04) : 795 - 804
  • [46] EGF Receptor Exposed to Oxidative Stress Acquires Abnormal Phosphorylation and Aberrant Activated Conformation That Impairs Canonical Dimerization
    Filosto, Simone
    Khan, Elaine M.
    Tognon, Emiliana
    Becker, Cathleen
    Ashfaq, Majid
    Ravid, Tommer
    Goldkorn, Tzipora
    [J]. PLOS ONE, 2011, 6 (08):
  • [47] Foley John, 2010, Semin Cell Dev Biol, V21, P951, DOI 10.1016/j.semcdb.2010.08.009
  • [48] FRENCH AR, 1994, J BIOL CHEM, V269, P15749
  • [49] ErbB3 expression and dimerization with EGFR influence pancreatic cancer cell sensitivity to erlotinib
    Frolov, Andrey
    Schuller, Kyle
    Tzeng, Ching-Wei D.
    Cannon, Emily E.
    Ku, Brandon C.
    Howard, J. Harrison
    Vickers, Selwyn M.
    Heslin, Martin J.
    Buchsbaum, Donald J.
    Arnoletti, J. Pablo
    [J]. CANCER BIOLOGY & THERAPY, 2007, 6 (04) : 548 - 554
  • [50] Erlotinib inhibits osteolytic bone invasion of human non-small-cell lung cancer cell line NCI-H292
    Furugaki, Koh
    Moriya, Yoichiro
    Iwai, Toshiki
    Yorozu, Keigo
    Yanagisawa, Mieko
    Kondoh, Kumiko
    Fujimoto-Ohuchi, Kaori
    Mori, Kazushige
    [J]. CLINICAL & EXPERIMENTAL METASTASIS, 2011, 28 (07) : 649 - 659
12345678910